Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-001651
Request Summary: Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate which was accepted into review on or after December 1, 2022. Identify the Canadian Reference Product, as described in section C.08.002.1 of the Food and Drug Regulations, to which the new drug in this desmopressin ANDS is compared.
Disposition: Disclosed in part
Number of pages: 3